CYNTHIA NORSCIA: Open Payments
NPI 1104456003 · BLOOMFIELD HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,654 in 44 payments from 10 companies in 2025. Trend: 2023 $140 · 2024 $1,415 · 2025 $1,654
Food & beverage: $1,654
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 14 | $505 |
| Alkermes, Inc. | 6 | $249 |
| Otsuka America Pharmaceutical, Inc. | 9 | $222 |
| Vanda Pharmaceuticals Inc. | 5 | $178 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $125 |
| Indivior Inc. | 1 | $125 |
| Braeburn Inc. | 1 | $91 |
| Neurocrine BioSciences, Inc. | 4 | $84 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 1 | $34 |
Products named: INVEGA SUSTENNA, FANAPT, LYBALVI, REXULTI, CAPLYTA, SUBLOCADE, SPRAVATO, BRIXADI.
Industry payments across MI — which companies pay providers there.
